Published November 2022 | Version v1
Journal article

Five‐year outcomes in liver transplant patients receiving everolimus with or without a calcineurin inhibitor: Results from the CERTITUDE study

Contributors

Others:

Description

Background and Aims: To report 5-year outcomes of the CERTITUDE study.Methods: An observational study in patients with liver transplantation (LTx) comparedthe long-term impact of immunosuppression (with/without a calcineurin inhibitor) onrenal function, cancers, major cardiovascular events (MACEs) and other safety parameters. All patients completing the 6-month SIMCER study were recruited and analysed according to treatment received at randomization and actual treatment receivedduring the follow-up.

Abstract

International audience

Additional details

Identifiers

URL
https://hal.science/hal-04183810
URN
urn:oai:HAL:hal-04183810v1

Origin repository

Origin repository
UNICA